Join our Patient Advisory Board

by Jazzmin Huber | Sep 27, 2022 | Research, Resources and Support

Applications are now open to join our patient advisory board. We are looking for 6 members of the osteosarcoma community to join our board and help direct our charity’s work. We want to hear your thoughts and ideas to ensure the work we do and the research we...

Could P2 Receptors Be Targets For Primary Bone Cancer Therapy?

by Katie Nightingale | Sep 20, 2022 | Research

Primary bone cancer (PBC) is a group of cancers that includes osteosarcoma (OS). Other cancers in this group are Ewing’s sarcoma, chondrosarcoma and chordoma. There have been few advances in the treatment of PBC for the past 40 years. This means there is an urgent...

Targeting Cancer Survival Mechanisms

by Jazzmin Huber | Sep 13, 2022 | Research

In the past cancers of the same type were often treated in the same way. However, not all cancers would respond to the same treatment. We now understand that even cancers of the same type can be very different and need different drugs. This is often due to their...

Osteosarcoma Research at Sarcoma UK

by Guest Blogger | Sep 6, 2022 | Research

There are so many fantastic charities working towards a common goal of improving outcomes for people with osteosarcoma (OS). This week Kate Quillin, Research Officer at Sarcoma UK, took over our blog to share their work. Sarcoma UK is the only cancer charity in the UK...

Understanding How Osteosarcoma Spreads

by Katie Nightingale | Aug 23, 2022 | Research

Osteosarcoma (OS) is a complex cancer with many questions that remain unanswered. The more we understand about how OS behaves, the better we will be able to plan treatment strategies. OS is currently treated using a combination of chemotherapy and surgery. Metastasis...

ICONIC: A Recruiting Osteosarcoma Trial

by Jazzmin Huber | Aug 16, 2022 | Clinical Trials, Research

In the 1970s the treatment for osteosarcoma (OS) was completely transformed by chemotherapy. Suddenly a cancer that previously had very few options was curable. However, since then there have been few changes to the treatment. Not only can the drugs cause long-term...